China Biologic Products, Inc. (NASDAQ: CBPO) is a prominent Chinese biopharmaceutical company that specializes in plasma-based therapies. The company's products are widely used for emergency medical situations and to prevent and treat life-threatening illnesses related to immune deficiencies. With its headquarters in Beijing, China Biologic produces more than 20 different dosage forms of plasma products through its majority owned subsidiary, Shandong Taibang Biological Products Co., Ltd., and wholly owned subsidiary, Guizhou Taibang Biological Products Co., Ltd.